Price:
Rs. 9,450.00
Sample Type: Serum
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the Neuronal Antibody Profile 1 at Metropolis Healthcare include?
It screens for important neuronal autoantibodies linked to autoimmune encephalitis and other neurological autoimmune disorders.
How does Metropolis Healthcare perform this neuronal antibody panel?
Metropolis Healthcare uses advanced immunoassays and high-sensitivity detection systems to identify specific neuronal antibodies in serum.
Who should consider taking this test at Metropolis Healthcare?
Individuals with unexplained seizures, memory issues, altered behavior, or suspected autoimmune neurological conditions should take this test.
How long do results take at Metropolis Healthcare?
Results typically take 5–7 days due to the complexity of antibody detection.
Is fasting required for this neuronal antibody test at Metropolis Healthcare?
No fasting is needed; a standard blood sample is sufficient.
Can this test at Metropolis Healthcare diagnose autoimmune encephalitis?
It helps identify antibody patterns that support diagnosis, though clinical evaluation and imaging are also essential.
How accurate is the Neuronal Antibody Profile 1 at Metropolis Healthcare?
Metropolis Healthcare follows stringent quality controls and uses advanced platforms to ensure high accuracy and reproducibility
Can this test help guide treatment at Metropolis Healthcare?
Yes, identifying specific neuronal antibodies helps neurologists plan targeted immunotherapy and monitor disease progression.